News
Teva Pharmaceutical Industries Limited TEVA and its partner, Biolojic Design Ltd., announced that TEVA has initiated investigational new drug or IND-enabling studies on BD9, a dual-specific ...
Teva and Glenmark are the two final companies to admit to the price-fixing charges. In a statement, Teva said it will pay $225 million over the course of five years.
BOSTON, Oct 10 (Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.TA), opens new tab has agreed to pay $450 million to resolve allegations it used charities that help cover Medicare patients ...
Teva Pharmaceutical Industries Limited’s TEVA stock has risen 12.9% in a month. Teva’s stock mainly gained after it announced first-quarter 2025 results on May 7. Teva’s first-quarter ...
June 13 (Reuters) - Teva Pharmaceuticals (TEVA.TA), opens new tab sued rival drugmaker Corcept Therapeutics (CORT.O), opens new tab in federal court in San Francisco on Thursday, accusing it of ...
Teva CMO Eric Hughes, M.D., Ph.D. (Teva) Teva’s mid- and late-stage pipeline largely hinges on four drugs, each of which falls into one of the company’s historic specialties in neuroscience ...
Teva Pharmaceutical Industries Limited’s TEVA stock has declined 10% in a month despite strong third-quarter results announced earlier this month. The company beat estimates for earnings as well ...
By Jan Hoffman Teva Pharmaceuticals, one of the country’s biggest manufacturers of generic opioids, announced a settlement in principle with some 2,500 local governments, states and tribes over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results